Pliant Therapeutics Stock Price

0.57 (1.95%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Pliant Therapeutics Inc PLRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.57 1.95% 29.87 29.2104 30.68 29.65 29.30 13:07:57
Bid Price Ask Price Spread Spread % News
29.56 29.79 0.23 0.77% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
645 49,527 $ 29.89 $ 1,480,339 301,819 21.50 - 35.63
Last Trade Time Type Quantity Stock Price Currency
13:07:57 2 $ 29.79 USD

Pliant Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.02B 34.20M 34.20M $ 57.05M $ 16.23M -0.04 27.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Pliant Therapeutics News

Date Time Source News Article
6/15/202016:41Edgar (US Regulatory)Statement of Ownership (sc 13g)
6/05/202016:05PR Newswire (US)Pliant Therapeutics Announces Closing of Initial Public..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PLRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week30.4635.6328.508831.68137,377-0.59-1.94%
1 Month22.5035.6321.5024.82263,6197.3732.76%
3 Months22.5035.6321.5024.82263,6197.3732.76%
6 Months22.5035.6321.5024.82263,6197.3732.76%
1 Year22.5035.6321.5024.82263,6197.3732.76%
3 Years22.5035.6321.5024.82263,6197.3732.76%
5 Years22.5035.6321.5024.82263,6197.3732.76%

Pliant Therapeutics Description

Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
Your Recent History
Pliant The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200702 17:23:01